The detailed molecular regulation of the autophagy system in cells via GLP-1 receptor signaling requires further investigation
Some peptides (IGF-1 LR3, MOTS-C) degrade faster and should be used within 14 to 21 days after reconstitution
Summary: Increased urination is not a recognised side effect of GLP-1 medications
Senescent cells promote tissue NAD decline during ageing via the activation of CD38 macrophages
J Clin Pathol 54(5):356361 Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins
The other approved anti-fibrotic drug, nintedanib, is a non-specific tyrosine kinase inhibitor, which prevents the phosphorylation multiple targets involved in the development of fibrosis including platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGFR) as well as the type II TGF- receptor (105, 106)